Injectable glucagon has been the primary treatment for ... of rescue therapy for healthcare practitioners, likening it to Mylan’s $1 billion EpiPen product for severe allergic reactions.

Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment ...

Veiga-Fernandes and colleagues reported on their findings in Science, in a paper titled “Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis.” In their report the ...

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...